| HOME >> BIOLOGY >> TECHNOLOGY |
The complete terms and conditions of the Tender Offer are set out in the Offer to Purchase, which is filed with the U.S. Securities and Exchange Commission. Taro shareholders may obtain copies of all of the offering documents, including the Offer to Purchase, free of charge at the SEC's website (http://www.sec.gov) or by directing a request to MacKenzie Partners, Inc., the Information Agent for the offer, at 105 Madison Avenue, New York, New York 10016, (212) 929-5500 (Call Collect) or Call Toll-Free (800) 322-2885, Email: tenderoffer@mackenziepartners.com.
Greenhill & Co., LLC is acting as the Dealer Manager for the Tender Offer and MacKenzie is acting as the Information Agent for the Tender Offer.
About Sun Pharmaceutical Industries Ltd.
Established in 1983, listed since 1994 and headquartered in India, Sun
Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:
SUNPHARMA, BSE: 524715) is an international, integrated, speciality
pharmaceutical company. It manufactures and markets a large basket of
pharmaceutical formulations as branded generics as well as generics in
India, U.S. and several other markets across the world. In India, the
company is a leader in niche therapy areas of psychiatry, neurology,
cardiology, diabetology, gastroenterology, and orthopedics. The company has
strong skills in product development, process chemistry, and manufacturing
of complex API, as well as dosage forms. More information about the company
can be found at http://www.sunpharma.com.
Contacts
Uday Baldota Mira Desai
Tel +91 22 6645 5645, Xtn 605 Tel +91 22 6645 5645, Xtn 606
Tel Direct +91 22 66455605 Tel Dire
'/>"/>
| SOURCE Sun Pharmaceutical Industries Ltd. Copyright©2008 PR Newswire. All rights reserved |